Feasibility and Acceptability of Digital Cognitive Screening Approaches for Older Adults in Primary Care

Background New immunotherapies for early‐stage Alzheimer’s disease (AD) have ushered in fresh hope for AD research and clinical care, but also highlight barriers to AD screening and timely diagnosis in the US. Digital cognitive assessments could potentially streamline screening and referrals for AD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2024-12, Vol.20 (S5), p.n/a
Hauptverfasser: Thompson, Louisa I., Lawrence, Molly, Rosenbaum, Jennifer A, Czech, Stephanie, Anthony, David C, Chandran, Rabin F, Goldberg, Arnold R, Vyshedskiy, Andrey, Elwy, Anashua R, Eaton, Charles B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background New immunotherapies for early‐stage Alzheimer’s disease (AD) have ushered in fresh hope for AD research and clinical care, but also highlight barriers to AD screening and timely diagnosis in the US. Digital cognitive assessments could potentially streamline screening and referrals for AD treatment and/or clinical trials. We report preliminary data on the feasibility and acceptability of three digital cognitive approaches for older adults completing Annual Wellness or routine follow‐up visits with a primary care provider (PCP). Methods Data were collected for an ongoing primary care‐based study in Rhode Island. Cognitive screening approaches included: 1) remote online screening with the Boston Online Cognitive Assessment (BOCA) prior to the PCP appointment, 2) self‐administered screening with the BOCA in the waiting room immediately before or after the appointment, and 3) provider‐administered screening during the appointment using the Digital Clock and Recall (Linus Health DCRTM). Participants also completed a 30‐minute, in‐clinic cognitive health consultation including the Montreal Cognitive Assessment (as a reference standard) to receive feedback and referral options. Five PCPs aided in protocol development through focus groups and participated in data collection. Potential participants were identified via EMR. Recruitment included mailings, MyChart messages and phone calls, and direct referrals from PCPs. Exclusion criteria: dementia or other neurological disease, score of
ISSN:1552-5260
1552-5279
DOI:10.1002/alz.092820